Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx(TM) Insertable Cardiac Monitor System
First ICM device with remote programming paired with dual-stage arrhythmia detection algorithm
MARLBOROUGH, Mass., June 29, 2020 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (... Devices, Cardiology, Monitoring, FDA Boston Scientific, LUX-Dx, Insertable Cardiac Monitor, arrhythmia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 29, 2020 Category: Pharmaceuticals Source Type: news
Complications After Colonoscopy Up for Those Aged ≥ 75
Other factors associated with risk include anemia, cardiac arrhythmia, hypertension, smoking history, obesity (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 26, 2020 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Journal, Source Type: news
How to Reboot Elective CV Procedures After COVID-19 Lockdown How to Reboot Elective CV Procedures After COVID-19 Lockdown
Top cardiology societies provide strategies and considerations for ramping up elective CV imaging, electrophysiology, and remote arrhythmia monitoring as restrictions ease.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 25, 2020 Category: Cardiology Tags: Cardiology News Source Type: news
Complete heart block secondary to flecainide toxicity: is it time for CYP2D6 genotype testing? - Poh BH, Lee JH, Abdul Haium AA, Choo TLJ.
Flecainide acetate is a Vaughan-Williams class IC antiarrhythmic drug prescribed for the treatment of supraventricular arrhythmias. It has a narrow therapeutic index and proarrhythmic effects even at therapeutic doses. Flecainide is metabolized by a CYP2D6... (Source: SafetyLit)
Source: SafetyLit - June 23, 2020 Category: International Medicine & Public Health Tags: Poisoning Source Type: news
Critically ill COVID-19 patients are 10 times more likely to develop cardiac arrhythmias
(University of Pennsylvania School of Medicine) Patients with COVID-19 who were admitted to an intensive care unit were 10 times more likely than other hospitalized COVID-19 patients to suffer cardiac arrest or heart rhythm disorders, according to a new study. Researchers say the results suggest that cardiac arrests and arrhythmias suffered by some patients with COVID-19 are likely triggered by a severe, systemic form of the disease and are and not the sole consequence of the viral infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2020 Category: Infectious Diseases Source Type: news
What Causes Bradycardia?
Discussion
Bradycardia is a heart rate below what the lowest value that is normal for age. Infants and children have higher heart rates that slowly decrease with age to adult levels. It is usually noted as an incidental finding because of increased vagal tone. Reasons for cardiology referral include associated heart murmur, syncope especially if associated with exercise or unusual triggers, other signs such as chest pain or palpitations, family history of sudden cardiac death, congenital heart disease or familial heart disease, bradycardic medication use, or unusual symptoms associated with the concern. Severe bradycardia ...
Source: PediatricEducation.org - June 22, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Daily Coffee May Lower Risk for Developing Arrhythmia
FRIDAY, June 19, 2020 -- Regular coffee consumption is associated with a significantly lower risk for arrhythmias, according to a study presented recently as part of the Heart Rhythm Society online meeting: HRS 2020 Science.
Eun-Jeong Kim, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 19, 2020 Category: Pharmaceuticals Source Type: news
Preventing Arrhythmias in COVID-19 Patients on Psychotropics Preventing Arrhythmias in COVID-19 Patients on Psychotropics
Patients with preexisting mental health conditions who are being treated for COVID-19 are particularly susceptible to clinical deterioration. Three mental health clinicians share their thoughts.Medscape Psychiatry (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - June 18, 2020 Category: Infectious Diseases Tags: Psychiatry Commentary Source Type: news
First known case of a potentially deadly heart rhythm disturbance induced by chloroquine therapy for COVID-19 reported
(Elsevier) A patient who met many of the published safety guidelines for chloroquine therapy against COVID-19 was observed to have a very abnormal ECG pattern after treatment began, leading to multiple episodes of torsade de pointes (TdP), a life-threatening arrhythmia in which the lower chambers of the heart beat out of sync with the upper chambers. Her condition was resolved after chloroquine was discontinued, investigators report in Heart Rhythm. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 18, 2020 Category: Infectious Diseases Source Type: news
Use of unproven COVID-19 therapies by African American patients poses risks
(Elsevier) Nearly one out of every 10 African Americans has a genetic variant that puts them inherently at an increased risk for ventricular arrhythmias and sudden cardiac death. Writing in the journal Heart Rhythm, the official publication of the Heart Rhythm Society and the Cardiac Electrophysiology Society, published by Elsevier, investigators observe that along with socioeconomic and cultural factors, this genetic risk factor may contribute to the racial health disparities that have been documented in victims of the COVID-19 pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 15, 2020 Category: Infectious Diseases Source Type: news
Research progress of aconitine toxicity and forensic analysis of aconitine poisoning - Gao X, Hu J, Zhang X, Zuo Y, Wang Y, Zhu S.
Chinese herbal medicines have been extensively used in China and other countries for centuries. Aconitine, a diterpenoid alkaloid extracted from Aconitum plants, has anti-inflammatory and analgesic activities, but can also induce severe arrhythmia and neur... (Source: SafetyLit)
Source: SafetyLit - June 11, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Evaluating the risks of arrhythmia following electrical injury: two cases of electrical injuries in the upper limbs - Jingo K, Kondo Y, Hirano Y, Inoue J, Kawasaki T, Miyoshi Y, Ishihara T, Okamoto K, Tanaka H.
Electrical injuries induce ventricular arrhythmias, which are lethal. Therefore, it is important to evaluate the risk of arrhythmias at initial presentation to the emergency department in cases of electrical injuries. Here, we report two cases with electri... (Source: SafetyLit)
Source: SafetyLit - June 4, 2020 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news
U.S. FDA Approves New Pediatric Formulation of SIRTURO ® (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO®
(bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multidrug-resistant tuberculosis (MDR‑TB). In the U.S., the medicine should be reserved for use when an effective treatment regimen cannot otherwise be provided. This indication received accelerated appro...
Source: Johnson and Johnson - May 27, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Bardy Expands Home Enrollment Program for Cardiac Patch Monitor
Bardy Diagnostics is expanding the home enrollment program for its cardiac patch monitor and won CE mark for a 14-day version of the device.
The Seattle, WA-based company said it was exploring more telehealth opportunities with Carnation Ambulatory Monitor (CAM) patch because of the rapidly evolving COVID-19 public health emergency. Typically, the CAM patch is applied to a patient in the clinic setting.
In a prepared statement Ken Nelson, chief commercial officer of Bardy Diagnostics said, “To help address the evolving needs of physicians and patients in this public health emergency, facilitat...
Source: MDDI - May 26, 2020 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Cardiovascular Source Type: news
Hydroxychloroquine Plus Macrolides No Benefit in COVID - 19
Hydroxychloroquine, chloroquine with or without macrolides linked to in - hospital mortality, arrhythmia (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 26, 2020 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news
